Cell Therapy Market Size, Share & Trends Report

Cell Therapy Market Size, Share & Trends Analysis Report By Therapy Type (Autologous (Stem Cell Therapies, Non-stem Cell Therapies), Allogeneic), By Therapeutic Area, By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-2-68038-701-8
  • Number of Pages: 110
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2022
  • Industry: Healthcare

Market Segmentation

  • Cell Therapy Type Outlook (Revenue, USD Million, 2018 - 2030)
    • Allogeneic Therapies
      • Stem Cell Therapies
        • Hematopoietic Stem Cell Therapies
        • Mesenchymal Stem Cell Therapies
      • Non-Stem Cell Therapies
        • Keratinocytes & Fibroblast-based Therapies
        • Others
    • Autologous Therapies
      • Stem Cell Therapies
        • BM, Blood, & Umbilical Cord-derived Stem Cells
        • Adipose Derived Cells
        • Others
      • Non-Stem Cell Therapies
        • T-Cell Therapies
          • CAR T Cell Therapy
          • T Cell Receptor (TCR)-based
        • Others
  • Cell Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
    • Oncology
    • Cardiovascular Disease (CVD)
    • Musculoskeletal Disorders
    • Dermatology
    • Others
  • Cell Therapy Regional Outlook (Revenue, USD Million, 2018 - 2030)
    • North America
      • North America Cell Therapy Market, By Therapy Type
        • Allogeneic Therapies
          • Stem Cell Therapies
            • Hematopoietic Stem Cell Therapies
            • Mesenchymal Stem Cell Therapies
          • Non-Stem Cell Therapies
            • Keratinocytes & Fibroblast-based Therapies
            • Others
        • Autologous Therapies
          • Stem Cell Therapies
            • BM, Blood, & Umbilical Cord-derived Stem Cells
            • Adipose Derived Cells
            • Others
          • Non-Stem Cell Therapies
            • T-Cell Therapies
              • CAR T Cell Therapy
              • T Cell Receptor (TCR)-based
            • Others
      • North America Cell Therapy Market, By Therapeutic Area
        • Oncology
        • Cardiovascular Disease (CVD)
        • Musculoskeletal Disorders
        • Dermatology
        • Others
      • U.S.
        • U.S. Cell Therapy Market, By Therapy Type
          • Allogeneic Therapies
            • Stem Cell Therapies
              • Hematopoietic Stem Cell Therapies
              • Mesenchymal Stem Cell Therapies
            • Non-Stem Cell Therapies
              • Keratinocytes & Fibroblast-based Therapies
              • Others
          • Autologous Therapies
            • Stem Cell Therapies
              • BM, Blood, & Umbilical Cord-derived Stem Cells
              • Adipose Derived Cells
              • Others
            • Non-Stem Cell Therapies
              • T-Cell Therapies
                • CAR T Cell Therapy
                • T Cell Receptor (TCR)-based
              • Others
        • U.S. Cell Therapy Market, By Therapeutic Area
          • Oncology
          • Cardiovascular Disease (CVD)
          • Musculoskeletal Disorders
          • Dermatology
          • Others
      • Canada
        • Canada Cell Therapy Market, By Therapy Type
          • Allogeneic Therapies
            • Stem Cell Therapies
              • Hematopoietic Stem Cell Therapies
              • Mesenchymal Stem Cell Therapies
            • Non-Stem Cell Therapies
              • Keratinocytes & Fibroblast-based Therapies
              • Others
          • Autologous Therapies
            • Stem Cell Therapies
              • BM, Blood, & Umbilical Cord-derived Stem Cells
              • Adipose Derived Cells
              • Others
            • Non-Stem Cell Therapies
              • T-Cell Therapies
                • CAR T Cell Therapy
                • T Cell Receptor (TCR)-based
              • Others
        • Canada Cell Therapy Market, By Therapeutic Area
          • Oncology
          • Cardiovascular Disease (CVD)
          • Musculoskeletal Disorders
          • Dermatology
          • Others
    • Europe
      • Europe Cell Therapy Market, By Therapy Type
        • Allogeneic Therapies
          • Stem Cell Therapies
            • Hematopoietic Stem Cell Therapies
            • Mesenchymal Stem Cell Therapies
          • Non-Stem Cell Therapies
            • Keratinocytes & Fibroblast-based Therapies
            • Others
        • Autologous Therapies
          • Stem Cell Therapies
            • BM, Blood, & Umbilical Cord-derived Stem Cells
            • Adipose Derived Cells
            • Others
          • Non-Stem Cell Therapies
            • T-Cell Therapies
              • CAR T Cell Therapy
              • T Cell Receptor (TCR)-based
            • Others
      • Europe Cell Therapy Market, By Therapeutic Area
        • Oncology
        • Cardiovascular Disease (CVD)
        • Musculoskeletal Disorders
        • Dermatology
        • Others
      • UK
        • UK Cell Therapy Market, By Therapy Type
          • Allogeneic Therapies
            • Stem Cell Therapies
              • Hematopoietic Stem Cell Therapies
              • Mesenchymal Stem Cell Therapies
            • Non-Stem Cell Therapies
              • Keratinocytes & Fibroblast-based Therapies
              • Others
          • Autologous Therapies
            • Stem Cell Therapies
              • BM, Blood, & Umbilical Cord-derived Stem Cells
              • Adipose Derived Cells
              • Others
            • Non-Stem Cell Therapies
              • T-Cell Therapies
                • CAR T Cell Therapy
                • T Cell Receptor (TCR)-based
              • Others
        • UK Cell Therapy Market, By Therapeutic Area
          • Oncology
          • Cardiovascular Disease (CVD)
          • Musculoskeletal Disorders
          • Dermatology
          • Others
      • Germany
        • Germany Cell Therapy Market, By Therapy Type
          • Allogeneic Therapies
            • Stem Cell Therapies
              • Hematopoietic Stem Cell Therapies
              • Mesenchymal Stem Cell Therapies
            • Non-Stem Cell Therapies
              • Keratinocytes & Fibroblast-based Therapies
              • Others
          • Autologous Therapies
            • Stem Cell Therapies
              • BM, Blood, & Umbilical Cord-derived Stem Cells
              • Adipose Derived Cells
              • Others
            • Non-Stem Cell Therapies
              • T-Cell Therapies
                • CAR T Cell Therapy
                • T Cell Receptor (TCR)-based
              • Others
        • Germany Cell Therapy Market, By Therapeutic Area
          • Oncology
          • Cardiovascular Disease (CVD)
          • Musculoskeletal Disorders
          • Dermatology
          • Others
      • Switzerland
        • Switzerland Cell Therapy Market, By Therapy Type
          • Allogeneic Therapies
            • Stem Cell Therapies
              • Hematopoietic Stem Cell Therapies
              • Mesenchymal Stem Cell Therapies
            • Non-Stem Cell Therapies
              • Keratinocytes & Fibroblast-based Therapies
              • Others
          • Autologous Therapies
            • Stem Cell Therapies
              • BM, Blood, & Umbilical Cord-derived Stem Cells
              • Adipose Derived Cells
              • Others
            • Non-Stem Cell Therapies
              • T-Cell Therapies
                • CAR T Cell Therapy
                • T Cell Receptor (TCR)-based
              • Others
        • SwitzerlandCell Therapy Market, By Therapeutic Area
          • Oncology
          • Cardiovascular Disease (CVD)
          • Musculoskeletal Disorders
          • Dermatology
          • Others
    • Asia Pacific
      • Asia Pacific Cell Therapy Market, By Therapy Type
        • Allogeneic Therapies
          • Stem Cell Therapies
            • Hematopoietic Stem Cell Therapies
            • Mesenchymal Stem Cell Therapies
          • Non-Stem Cell Therapies
            • Keratinocytes & Fibroblast-based Therapies
            • Others
        • Autologous Therapies
          • Stem Cell Therapies
            • BM, Blood, & Umbilical Cord-derived Stem Cells
            • Adipose Derived Cells
            • Others
          • Non-Stem Cell Therapies
            • T-Cell Therapies
              • CAR T Cell Therapy
              • T Cell Receptor (TCR)-based
            • Others
      • Asia Pacific Cell Therapy Market, By Therapeutic Area
        • Oncology
        • Cardiovascular Disease (CVD)
        • Musculoskeletal Disorders
        • Dermatology
        • Others
      • Japan
        • Japan Cell Therapy Market, By Therapy Type
          • Allogeneic Therapies
            • Stem Cell Therapies
              • Hematopoietic Stem Cell Therapies
              • Mesenchymal Stem Cell Therapies
            • Non-Stem Cell Therapies
              • Keratinocytes & Fibroblast-based Therapies
              • Others
          • Autologous Therapies
            • Stem Cell Therapies
              • BM, Blood, & Umbilical Cord-derived Stem Cells
              • Adipose Derived Cells
              • Others
            • Non-Stem Cell Therapies
              • T-Cell Therapies
                • CAR T Cell Therapy
                • T Cell Receptor (TCR)-based
              • Others
        • Japan Cell Therapy Market, By Therapeutic Area
          • Oncology
          • Cardiovascular Disease (CVD)
          • Musculoskeletal Disorders
          • Dermatology
          • Others
      • China
        • China Cell Therapy Market, By Therapy Type
          • Allogeneic Therapies
            • Stem Cell Therapies
              • Hematopoietic Stem Cell Therapies
              • Mesenchymal Stem Cell Therapies
            • Non-Stem Cell Therapies
              • Keratinocytes & Fibroblast-based Therapies
              • Others
          • Autologous Therapies
            • Stem Cell Therapies
              • BM, Blood, & Umbilical Cord-derived Stem Cells
              • Adipose Derived Cells
              • Others
            • Non-Stem Cell Therapies
              • T-Cell Therapies
                • CAR T Cell Therapy
                • T Cell Receptor (TCR)-based
              • Others
        • China Cell Therapy Market, By Therapeutic Area
          • Oncology
          • Cardiovascular Disease (CVD)
          • Musculoskeletal Disorders
          • Dermatology
          • Others
      • India
        • India Cell Therapy Market, By Therapy Type
          • Allogeneic Therapies
            • Stem Cell Therapies
              • Hematopoietic Stem Cell Therapies
              • Mesenchymal Stem Cell Therapies
            • Non-Stem Cell Therapies
              • Keratinocytes & Fibroblast-based Therapies
              • Others
          • Autologous Therapies
            • Stem Cell Therapies
              • BM, Blood, & Umbilical Cord-derived Stem Cells
              • Adipose Derived Cells
              • Others
            • Non-Stem Cell Therapies
              • T-Cell Therapies
                • CAR T Cell Therapy
                • T Cell Receptor (TCR)-based
              • Others
        • India Cell Therapy Market, By Therapeutic Area
          • Oncology
          • Cardiovascular Disease (CVD)
          • Musculoskeletal Disorders
          • Dermatology
          • Others
      • South Korea
        • South Korea Cell Therapy Market, By Therapy Type
          • Allogeneic Therapies
            • Stem Cell Therapies
              • Hematopoietic Stem Cell Therapies
              • Mesenchymal Stem Cell Therapies
            • Non-Stem Cell Therapies
              • Keratinocytes & Fibroblast-based Therapies
              • Others
          • Autologous Therapies
            • Stem Cell Therapies
              • BM, Blood, & Umbilical Cord-derived Stem Cells
              • Adipose Derived Cells
              • Others
            • Non-Stem Cell Therapies
              • T-Cell Therapies
                • CAR T Cell Therapy
                • T Cell Receptor (TCR)-based
              • Others
        • South Korea Cell Therapy Market, By Therapeutic Area
          • Oncology
          • Cardiovascular Disease (CVD)
          • Musculoskeletal Disorders
          • Dermatology
          • Others
    • Rest of the World
      • Rest of the World Cell Therapy Market, By Therapy Type
        • Allogeneic Therapies
          • Stem Cell Therapies
            • Hematopoietic Stem Cell Therapies
            • Mesenchymal Stem Cell Therapies
          • Non-Stem Cell Therapies
            • Keratinocytes & Fibroblast-based Therapies
            • Others
        • Autologous Therapies
          • Stem Cell Therapies
            • BM, Blood, & Umbilical Cord-derived Stem Cells
            • Adipose Derived Cells
            • Others
          • Non-Stem Cell Therapies
            • T-Cell Therapies
              • CAR T Cell Therapy
              • T Cell Receptor (TCR)-based
            • Others
      • Rest of the World Cell Therapy Market, By Therapeutic Area
        • Oncology
        • Cardiovascular Disease (CVD)
        • Musculoskeletal Disorders
        • Dermatology
        • Others

Cell Therapy Market Dynamics

Driver: Rise in the number of clinical studies pertaining to the development of cellular therapies

The rising number of clinical studies focusing on the development of cellular therapies reflects a growing recognition of the potential of cellular therapies across a spectrum of medical conditions and highlights the increasing focus of pharmaceutical companies to explore & harness the therapeutic potential of cells. For instance, as of January 2023, over 2,000 clinical trials were ongoing in the cell and gene therapy space. One significant factor fueling the high number of clinical studies is the promising outcomes observed in early-phase trials. Positive results from initial studies have instilled confidence in the efficacy and safety of cellular therapies, encouraging further exploration and investment. Conditions such as cancer, autoimmune disorders, and degenerative diseases are being targeted, with researchers aiming to unlock the full therapeutic potential of various cell types, including stem cells & immune cells.

Driver: Rising adoption of regenerative medicine

The convergence of scientific advancements, increased understanding of cellular processes, and a growing emphasis on personalized medicine have propelled regenerative medicine to the forefront of medical innovation, significantly impacting the market’s growth. Cell therapies form an important component of regenerative medicine and hold immense potential in treating various medical conditions, including degenerative disorders, autoimmune diseases, and various types of cancer. The versatility of cell therapies allows for targeted interventions that stimulate tissue repair, modulate immune responses, or replace damaged cells, offering novel and effective treatment options where conventional approaches may fall short. This has led to an increasing usage of cell therapies as a part of regenerative medicine treatment regimes.

Restraint: Ethical concerns related to stem cell research

Ethical concerns related to stem cell research pose a significant restraint for the cell therapy market, creating challenges in R&D and public acceptance. For instance, concerns over the use of embryonic stem cells have been a prominent issue in this field. The extraction of these cells requires the destruction of embryos, which raises moral objections. This has led to stringent regulations and limitations on the use of embryonic stem cells in certain regions, hindering the progress of R&D in those areas. The controversy surrounding the ethical implications has also resulted in limited funding for embryonic stem cell projects. In addition, concerns about the ownership of stem cells, informed consent, and the potential exploitation of vulnerable populations raise important ethical dilemmas. The lack of a universally accepted ethical framework for stem cell research hinders research in the market.

What Does This Report Include?

This section will provide insights into the contents included in this cell therapy market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Cell therapy market qualitative analysis

  • Industry overview

  • Industry trends

  • Market drivers and restraints

  • Market size

  • Growth prospects

  • Porter’s analysis

  • PESTEL analysis

  • Key market opportunities prioritized

  • Competitive landscape

    • Company overview

    • Financial performance

    • Product benchmarking

    • Latest strategic developments

Cell therapy market quantitative analysis

  • Market size, estimates, and forecast from 2018 to 2030

  • Market estimates and forecast for product segments up to 2030

  • Regional market size and forecast for product segments up to 2030

  • Market estimates and forecast for application segments up to 2030

  • Regional market size and forecast for application segments up to 2030

  • Company financial performance

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon